Endurance Wealth Management, Inc. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,047 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Endurance Wealth Management, Inc. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2023$22
+10.0%
4810.0%0.00%0.0%
Q1 2023$20
-20.0%
4810.0%0.00%
-25.0%
Q4 2022$25
-99.9%
4810.0%0.00%0.0%
Q3 2022$26,000
-16.1%
4810.0%0.00%
-20.0%
Q2 2022$31,000
-16.2%
4810.0%0.01%0.0%
Q1 2022$37,000
-9.8%
4810.0%0.01%
+25.0%
Q4 2021$41,000
+5.1%
4810.0%0.00%0.0%
Q3 2021$39,000
+2.6%
4810.0%0.00%0.0%
Q2 2021$38,000
-7.3%
4810.0%0.00%
-20.0%
Q1 2021$41,000
+5.1%
4810.0%0.01%0.0%
Q4 2020$39,0000.0%4810.0%0.01%
-16.7%
Q3 2020$39,000
-4.9%
4810.0%0.01%
-14.3%
Q2 2020$41,000
+5.1%
4810.0%0.01%0.0%
Q1 2020$39,000
-2.5%
4810.0%0.01%
+16.7%
Q4 2019$40,000
-4.8%
4810.0%0.01%
-14.3%
Q3 2019$42,000
+7.7%
4810.0%0.01%
+16.7%
Q2 2019$39,0000.0%4810.0%0.01%0.0%
Q1 2019$39,000
+21.9%
4810.0%0.01%0.0%
Q4 2018$32,000
-13.5%
4810.0%0.01%0.0%
Q3 2018$37,000
+2.8%
4810.0%0.01%0.0%
Q2 2018$36,000
+16.1%
4810.0%0.01%
+20.0%
Q1 2018$31,0000.0%4810.0%0.01%0.0%
Q4 2017$31,000
+3.3%
4810.0%0.01%0.0%
Q3 2017$30,000
+3.4%
4810.0%0.01%0.0%
Q2 2017$29,000
+16.0%
4810.0%0.01%
+25.0%
Q1 2017$25,000
+19.0%
4810.0%0.00%0.0%
Q4 2016$21,000
-8.7%
4810.0%0.00%0.0%
Q3 2016$23,000
+4.5%
4810.0%0.00%0.0%
Q2 2016$22,000
+4.8%
481
-3.8%
0.00%
+33.3%
Q1 2016$21,000
+10.5%
5000.0%0.00%
-25.0%
Q4 2015$19,000
+11.8%
5000.0%0.00%
+33.3%
Q3 2015$17,000
-51.4%
5000.0%0.00%
-50.0%
Q2 2015$35,0005000.01%
Other shareholders
BAXTER INTL INC shareholders Q4 2018
NameSharesValueWeighting ↓
Tavio Capital LLC 68,405$5,890,0007.81%
Iron Triangle Partners LP 330,000$28,413,0007.16%
Veritas Asset Management LLP 8,942,428$769,943,0005.64%
TSFG, LLC 93,405$8,042,0005.31%
GENERATION INVESTMENT MANAGEMENT LLP 10,606,094$913,185,0005.27%
Third Point 4,000,000$344,400,0004.72%
Avidity Partners Management LP 800,900$68,957,0004.42%
Palmer Knight Co 62,275$5,362,0004.17%
Eos Focused Equity Management, L.P. 36,786$3,167,0003.70%
Dundas Partners LLP 196,133$16,887,0003.69%
View complete list of BAXTER INTL INC shareholders